HOME >> BIOLOGY >> NEWS
Imaging apparatus characterizes drops in 'dirty' laboratory environments

CHAMPAIGN, Ill. - A high-fidelity spectrometric system for studying the behavior of drops and particles in industrial flame reactors has been constructed by researchers at the University of Illinois at Urbana-Champaign in collaboration with researchers at the University of Arizona. The instrument was used to study the potential of thermal combustors for reducing the volume of liquid nuclear wastes for safe, long-term storage.

Vitrification of radioactive waste into glassy solids is the most popular approach for disposal. By spraying radioactive sludge into a high-temperature combustor, essentially all the water and other nonradioactive material could be removed, leaving only the radioactive metallic elements to be vitrified for burial. Under optimized conditions, up to 99.99 percent of the metal ions in a waste stream can be scavenged in the combustor.

"That kind of efficiency would be great for most applications, but it's not good enough when dealing with radioactive waste," said Alexander Scheeline, a professor of chemistry at Illinois. "Understanding the cause of the unscavenged fraction and devising a way to reduce it are essential if thermal processing is to be used for nuclear waste treatment."

One possible explanation is that large "rogue" drops are responsible for the unscavenged metals, Scheeline said. These drops do not pass through the hottest zones in the combustor, resulting in only partial vaporization.

To investigate the role of rogue drops in this process, Scheeline and his colleagues -- Illinois postdoctoral researcher Jerry Cabalo, Arizona professor and head of chemical and environmental engineering Jost Wendt, and Arizona graduate student John Schmidt -- developed an optical system to monitor drop sizes and trajectories at very high spatial resolutions.

"In the thermal waste destruction process, small particle formation is also very important," Scheeline said. "Metals released into the gas phase readily
'"/>

Contact: James E. Kloeppel
kloeppel@uiuc.edu
217-244-1073
University of Illinois at Urbana-Champaign
20-Sep-2002


Page: 1 2

Related biology news :

1. Imaging the healing heart
2. Imaging study shows brain maturing
3. Imaging the brain solving problems through insight
4. Imaging technique reveals new structure in retinal cells
5. Imaging technique discovered at Stanford monitors cancer cell proliferation
6. Imaging technique may help in confirming, monitoring treatment of malignant brain tumors
7. Imaging study provides new information on how the brain processes sounds of different tones
8. New Imaging Technique Pinpoints Dead Heart Muscle
9. Imaging Studies Illuminate Brains Response To Cocaine
10. Yale scientists give the Golgi apparatus its own identity, paving the way for more targeted cancer research
11. Procedure, new apparatus may allow relief from incontinence

Post Your Comments:
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: